Neil Cashman

Company: ProMIS Neurosciences

Job title: Chief Scientific Officer & Co-Founder

Seminars:

Developing a Computational Method for Targeting Only the Toxic Misfolded Proteins in Alzheimer’s & Parkinson’s Disease 11:30 am

Rationale for reducing toxicity by only targeting oligomeric forms Demonstrating promising applications of the idea for targeting toxic species of amyloid, tau and alpha-synuclein Leveraging the model to identify more efficacious, less toxic targetsRead more

day: Conference Day Two - Track One